03:37 PM EDT, 06/11/2024 (MT Newswires) -- Microbot Medical ( MBOT ) filed a registration statement Tuesday for the issuance of 3.2 million common shares if the selling stockholders exercise their preferred investment options.

If the selling stockholders sell the securities, Microbot will not receive any proceeds from such sale, but the company may receive about $4.85 million in proceeds if all of the preferred investment options are exercised.

Proceeds, if any, will be allocated to working capital, the company said.

Price: 1.07, Change: -0.03, Percent Change: -2.73